Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.8 - $5.41 $7,380 - $22,181
4,100 Added 25.95%
19,900 $0
Q3 2022

Nov 14, 2022

BUY
$2.02 - $3.38 $606 - $1,014
300 Added 1.94%
15,800 $4,000
Q2 2022

Aug 12, 2022

BUY
$2.14 - $4.15 $1,284 - $2,490
600 Added 4.03%
15,500 $2,000
Q1 2022

May 12, 2022

BUY
$4.73 - $7.18 $70,477 - $106,982
14,900 New
14,900 $20,000

Others Institutions Holding SLS

About SELLAS Life Sciences Group, Inc.


  • Ticker SLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,551,900
  • Market Cap $19.5M
  • Description
  • SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...
More about SLS
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.